Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 261 publications
Implementation of ddaE neuron growth mechanism in graph grammar replicates biological features.
Journal: bioRxiv : the preprint server for biology
Published: August 20, 2026
BCL11B targeting in tumor CD8 + T cells amplifies anti-tumor response by blocking exhaustion while promoting stemness and cytotoxicity.
Journal: bioRxiv : the preprint server for biology
Published: August 15, 2026
Dual stimulation of CD40 and 41BB pathways during ex-vivo TIL expansion enhances CD8+ T cell expansion.
Journal: bioRxiv : the preprint server for biology
Published: August 01, 2026
Dual stimulation of CD40 and 41BB pathways during ex-vivo TIL expansion enhances CD8+ T cell expansion.
Journal: bioRxiv : the preprint server for biology
Published: August 01, 2026
Dual-degenerate TCRs target multiple KRAS hotspot and HLA-A3 family combinations.
Journal: Research square
Published: June 29, 2026
Evidence of genetic susceptibility to immune-related dermatitis in patients with melanoma treated with immune checkpoint inhibitors.
Journal: Melanoma research
Published: May 19, 2026
Immunologic determinants of infusion products and the tumor microenvironment govern response to TIL therapy in advanced melanoma.
Journal: Med (New York, N.Y.)
Published: March 17, 2026
CAR Signaling Informs Mechanisms to Enhance Metabolism and Function in γδ T Cells.
Journal: Research square
Published: February 12, 2026
CAR Signaling Informs Mechanisms to EnhanceMetabolism and Function in γδ T Cells.
Journal: Research square
Published: February 12, 2026
Editor's Note: Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.
Journal: Cancer discovery
Published: September 17, 2025
Intratumoral Sotigalimab with Pembrolizumab Induces Rapid Activation of Antigen-Presenting Cells and Drives Antitumor Responses in Non-injected Tumors in Metastatic Melanoma: A Phase I/II Study.
Journal: Cancer discovery
Published: September 08, 2025
Last Updated: 09/26/2026